Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The pathogenesis of acquired immunodeficiency syndrome-associated primary central nervous system lymphoma (AIDS-associated PCNSL) remains unclear. However, cell adhesion molecules have been reported to be strongly associated with PCNSL. In this study, we established Epstein-Barr virus (EBV)- transformed lymphoblastoid cell lines (LCLs) from HIV-positive patients (LCLHIV) and normal individuals (LCLN). The expression of CD18 antigen by LCLHIV was stronger than that by LCLN. We performed a cell adhesion assay using ISO-HAS, which is the human hemangiosarcoma cell line and expresses intercellular adhesion molecule 1 (CD54). The binding rates of LCLHIV and ISO-HAS without stimulation were higher than those of LCLN. Further, we demonstrated that azidothymidine or simvastatin inhibited the binding rates of LCLHIV and ISO-HAS more significantly than those of LCLN. Further, the levels of interleukin (IL)-8, a CD18 inducer, were higher in LCLHIV than in LCLN. We conclude that interaction between IL-8 and CD18 may be critical to AIDS-related PCNSL. © W.S. Maney & Son Ltd 2012.

Cite

CITATION STYLE

APA

Sasakawa, A., Hirase, C., Yamaguchi, T., Morita, Y., Miyatake, J. ichi, Matsumura, I., & Maeda, Y. (2012). Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection. Hematology, 17(3), 144–150. https://doi.org/10.1179/102453312X13376952196377

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free